118 related articles for article (PubMed ID: 24388536)
21. Estimation of malignant transformation rate in cases of oral epithelial dysplasia and lichen planus using immunohistochemical expression of Ki-67, p53, BCL-2, and BAX markers.
Shailaja G; Kumar JV; Baghirath PV; Kumar U; Ashalata G; Krishna AB
Dent Res J (Isfahan); 2015; 12(3):235-42. PubMed ID: 26005463
[TBL] [Abstract][Full Text] [Related]
22. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients.
Silverman S; Gorsky M; Lozada F
Cancer; 1984 Feb; 53(3):563-8. PubMed ID: 6537892
[TBL] [Abstract][Full Text] [Related]
23. Drug-induced osteoporosis: from Fuller Albright to aromatase inhibitors.
Byreddy DV; Bouchonville MF; Lewiecki EM
Climacteric; 2015; 18 Suppl 2():39-46. PubMed ID: 26488130
[TBL] [Abstract][Full Text] [Related]
24. Malignant transformation of oral leukoplakia: a systematic review of observational studies.
Warnakulasuriya S; Ariyawardana A
J Oral Pathol Med; 2016 Mar; 45(3):155-66. PubMed ID: 26189354
[TBL] [Abstract][Full Text] [Related]
25. RETRACTED: Straticyte demonstrates prognostic value over oral epithelial dysplasia grade for oral potentially malignant lesion assessment.
Hwang JTK; Gu YR; Dickson BJ; Shen M; Ralhan R; Walfish PG; Mock D; Pritzker KPH
Oral Oncol; 2017 Sep; 72():1-6. PubMed ID: 28797444
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives.
Seibel MJ; Cooper MS; Zhou H
Lancet Diabetes Endocrinol; 2013 Sep; 1(1):59-70. PubMed ID: 24622268
[TBL] [Abstract][Full Text] [Related]
27. Leuloplakia - review of a potentially malignant disorder.
Abidullah M; Kiran G; Gaddikeri K; Raghoji S; Ravishankar T S
J Clin Diagn Res; 2014 Aug; 8(8):ZE01-4. PubMed ID: 25302287
[TBL] [Abstract][Full Text] [Related]
28. Oral potentially malignant disorders: risk of progression to malignancy.
Speight PM; Khurram SA; Kujan O
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):612-627. PubMed ID: 29396319
[TBL] [Abstract][Full Text] [Related]
29. Management update of potentially premalignant oral epithelial lesions.
Awadallah M; Idle M; Patel K; Kademani D
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):628-636. PubMed ID: 29656948
[TBL] [Abstract][Full Text] [Related]
30. Oral epithelial dysplasia: Classifications and clinical relevance in risk assessment of oral potentially malignant disorders.
Ranganathan K; Kavitha L
J Oral Maxillofac Pathol; 2019; 23(1):19-27. PubMed ID: 31110412
[TBL] [Abstract][Full Text] [Related]
31. Oral Epithelial Dysplasia and Premalignancy.
Woo SB
Head Neck Pathol; 2019 Sep; 13(3):423-439. PubMed ID: 30887394
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis.
Mello FW; Miguel AFP; Dutra KL; Porporatti AL; Warnakulasuriya S; Guerra ENS; Rivero ERC
J Oral Pathol Med; 2018 Aug; 47(7):633-640. PubMed ID: 29738071
[TBL] [Abstract][Full Text] [Related]
33. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype.
Iocca O; Sollecito TP; Alawi F; Weinstein GS; Newman JG; De Virgilio A; Di Maio P; Spriano G; Pardiñas López S; Shanti RM
Head Neck; 2020 Mar; 42(3):539-555. PubMed ID: 31803979
[TBL] [Abstract][Full Text] [Related]
34. Applying Machine Learning for Enhanced MicroRNA Analysis: A Companion Risk Tool for Oral Squamous Cell Carcinoma in Standard Care Incisional Biopsy.
Pruthi N; Yap T; Moore C; Cirillo N; McCullough MJ
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672474
[TBL] [Abstract][Full Text] [Related]
35. Human Papillomavirus-Associated Oral Epithelial Dysplasia: A Practical Approach to Make the Diagnosis.
Parchami K; Derakhshan S; Saffar H; Aminishakib P; Shamshiri AR; Afshar S
Iran J Med Sci; 2024 Mar; 49(3):186-195. PubMed ID: 38584651
[TBL] [Abstract][Full Text] [Related]
36. Effect of valproic acid on histone deacetylase expression in oral cancer (Review).
Al-Khafaji ASK; Wang LM; Alabdei HH; Liloglou T
Oncol Lett; 2024 May; 27(5):197. PubMed ID: 38516679
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotypic and Gene Expression Analyses of the Inflammatory Microenvironment in High-Grade Oral Epithelial Dysplasia and Oral Lichen Planus.
Flores-Hidalgo A; Phero J; Steward-Tharp S; Williamson M; Paquette D; Krishnan D; Padilla R
Head Neck Pathol; 2024 Mar; 18(1):17. PubMed ID: 38456941
[TBL] [Abstract][Full Text] [Related]
38. Impact of dysplasia at resection margin on oncologic outcome after curative resection of oral tongue squamous cell carcinoma: significance of high-grade dysplastic resection margin.
Kim Y; Lee C; Heo Y; Jung SH; Kang YJ; Park SY; Chung MK; Jeong HS; Son YI; Cho J; Baek CH; Choi N
Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):441-449. PubMed ID: 37792215
[TBL] [Abstract][Full Text] [Related]
39. A digital score of peri-epithelial lymphocytic activity predicts malignant transformation in oral epithelial dysplasia.
Bashir RMS; Shephard AJ; Mahmood H; Azarmehr N; Raza SEA; Khurram SA; Rajpoot NM
J Pathol; 2023 Aug; 260(4):431-442. PubMed ID: 37294162
[TBL] [Abstract][Full Text] [Related]
40. Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, New Orleans, LA, March 12, 2023: Oral Cavity Dysplasia: Why Does Histologic Grading Continue to be Contentious?
Wolk R; Lingen MW
Head Neck Pathol; 2023 Jun; 17(2):292-298. PubMed ID: 37184731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
